Brief: Stephen From Resigns As Executive Chairman Of Kiora Pharmaceuticals
01/02/2022 11:50
Feb 1 (Reuters) - Kiora Pharmaceuticals Inc KPRX.O :
* KIORA PHARMACEUTICALS - EFFECTIVE OF JAN 31, 2022, STEPHEN
FROM
VOLUNTARILY RESIGNED AS EXECUTIVE CHAIRMAN OF CO AND AS A MEMBER
OF BOARD
* KIORA PHARMACEUTICALS INC - BOARD APPOINTED PAUL CHANEY AS
NON-EXECUTIVE CHAIRMAN OF BOARD
Source text for Eikon: ID:
Further company coverage: KPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing